News from sarcode bioscience, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 25, 2013, 09:00 ET

SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.

 SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a...

Jan 08, 2013, 08:00 ET

First Subject Enrolled in OPUS-2, SARcode Bioscience's Second Pivotal Study of Lifitegrast Ophthalmic Solution

 SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial subject has been enrolled in a second...

Oct 23, 2012, 07:00 ET

SARcode Bioscience Announces Positive Topline Results from Phase 3 Dry Eye Study of Lifitegrast

 SARcode Bioscience, Inc., announced topline results from OPUS-1, a pivotal Phase 3 study of lifitegrast ophthalmic solution, 5.0%, versus...

Mar 05, 2012, 09:00 ET
SARcode Bioscience Announces Series B Financing to Support Innovative Dry Eye Program.  (PRNewsFoto/SARcode Bioscience, Inc.)

Last Patient Enrolled in Pivotal Phase 3 Dry Eye Study (OPUS-1) of SAR 1118 Ophthalmic Solution

 SARcode Bioscience, Inc., a privately held biopharmaceutical company, announced today that it has completed patient enrollment in...

Sep 14, 2011, 13:02 ET
SARcode Bioscience Announces Series B Financing to Support Innovative Dry Eye Program.  (PRNewsFoto/SARcode Bioscience, Inc.)

First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution

SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial patient has been enrolled in the company's...

Jul 18, 2011, 07:00 ET
SARcode Bioscience Announces Series B Financing to Support Innovative Dry Eye Program.  (PRNewsFoto/SARcode Bioscience, Inc.)

SARcode Bioscience Completes $44 Million Series B Financing

SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity...